Phase II Trial of Trastuzumab Followed by Weekly Paclitaxel/Carboplatin As First-Line Treatment for Patients With Metastatic Breast Cancer - Concepedia

Concepedia

Publication | Closed Access

Phase II Trial of Trastuzumab Followed by Weekly Paclitaxel/Carboplatin As First-Line Treatment for Patients With Metastatic Breast Cancer

99

Citations

18

References

2004

Year

Howard A. Burris, Denise A. Yardley, Suzanne F. Jones, Gerry Ann Houston, Catherine M. Broome, Dana S. Thompson, F. Anthony Greco, M. White, John D. Hainsworth

Journal of Clinical Oncology

Abstract

This trial confirms the activity and tolerability of weekly paclitaxel/carboplatin alone or in combination with trastuzumab in women with HER-2 overexpressing metastatic breast cancer.

References

	Year	Citations

Page 1